Xenetic Biosciences Inc (XBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 11,528 | 10,368 | 638 | 5,600 | 4,115 |
| Receivables | N/A | N/A | N/A | N/A | 3,000 |
| TOTAL | $12,370 | $11,090 | $1,194 | $5,885 | $8,339 |
| Non-Current Assets | |||||
| PPE Net | N/A | 1 | 5 | 28 | 42 |
| Intangibles | 0 | 9,243 | 12,527 | 12,527 | 12,527 |
| Other Non-Current Assets | 810 | 1,213 | 706 | 725 | 66 |
| TOTAL | $810 | $10,457 | $13,237 | $13,279 | $12,635 |
| Total Assets | $13,180 | $21,547 | $14,431 | $19,164 | $20,974 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 327 | 931 | 934 | 787 | 1,007 |
| Accrued Expenses | 610 | 484 | 666 | 1,136 | 839 |
| TOTAL | $937 | $1,415 | $1,600 | $1,944 | $1,866 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 27 | 0 | 0 | 0 | 20 |
| TOTAL | $27 | $2,919 | $2,919 | $2,919 | $2,938 |
| Total Liabilities | $964 | $4,334 | $4,518 | $4,862 | $4,804 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 875 | 628 | 87 | 73 | 72 |
| Common Shares | 9 | 6 | 1 | 9 | 9 |
| Retained earnings | -176,902 | -166,009 | -153,234 | -145,933 | -142,338 |
| Other shareholders' equity | -28 | -27 | -26 | -26 | -27 |
| TOTAL | $12,216 | $17,213 | $9,913 | $14,302 | $16,170 |
| Total Liabilities And Equity | $13,180 | $21,547 | $14,431 | $19,164 | $20,974 |